Purchase Order 75N98018P00598

Award Date 8/23/18
Potential Completion Date 10/28/22
Potential Value $95K
Ultimate Awardee
Stemcell Tecnologies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company that provides specialized cell culture media, cell separation systems, and other life sciences research products. The contract is for the provision of a RoboSep LTD warranty with a preventive maintenance package for a...
This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, is for the purchase of four RoboSep Limited Warranty units (Catalog # 20200, S/N RS-1232) at a total ceiling value of $14,970.00. The contract was awarded on February 16, 2012 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award does not have a set-aside designation. As a prime contractor, Stemcell...
This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer, a civilian agency, to Stemcell Technologies Inc., a for-profit Canadian biotechnology company. The contract, valued at $14,677.50, is for the provision of maintenance services for Stemcell Technologies' proprietary research tools and supplies. Stemcell Technologies Inc. is the prime contractor and there is no indication of any major subcontractors. The contract is not set aside for small...
This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies. The $7,725.00 firm fixed-price purchase order is for a RoboSep LTD warranty with a preventative maintenance package, providing one year of service support for the automated cell separation instrument. The contract is not set aside...
The U.S. Department of Health and Human Services (HHS) awarded a firm fixed-price Purchase Order contract worth $24,454.50 to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies. This contract, awarded on August 21, 2014, is not set aside for small businesses. Stemcell Technologies Inc. primarily...
This is a firm fixed-price delivery order for $47,405.00 awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada. The contract is for a fully automated cell separator system called RoboSep, which automates the labeling and magnetic separation of cells, supporting the NIA's biomedical research activities. This contract is not...
This is a $24,970.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which has no set-aside designation, is for the delivery of various cell culture research products, such as cell isolation kits, cell culture media, and automated cell separation instruments, to support biomedical...
The U.S. government awarded a Firm Fixed Price Delivery Order contract to Stemcell Technologies Inc., a Canadian biotechnology company, for the provision of laboratory equipment and supplies. The contract has a ceiling value of $47,405.00 and runs through November 25, 2009. It was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Stemcell Technologies...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to STEMCELL Technologies Inc., a foreign-owned, for-profit biotechnology company. The $87,530 contract provides for preventive maintenance and service on two RoboSep cell separators used by the NIH's Department of Transfusion Medicine for automated isolation of cells for chimerism testing on bone marrow and stem cell transplant patients. The contract has a base year plus four one-year...

This is a firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services, to Stemcell Technologies Inc., a Canadian biotechnology company, to purchase a RoboSep-S automated cell separation system with a 5-year warranty and maintenance service. The contract, valued at $94,612.00, does not have a small business set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian parent company Stemcell Technologies, which has a significant presence supplying specialized biological materials, laboratory supplies, and scientific equipment to various federal research institutions, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of Veterans Affairs. The parent company Stemcell Technologies also holds a $10 million Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition Operations, enabling streamlined procurement of research materials across multiple NIH institutes.

Generated 4/1/25, 4:55 PM